1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Global Biosimilars Industry 2015 Market Research Report

Global Biosimilars Industry 2015 Market Research Report

  • November 2015
  • -
  • QY Research Group
  • -
  • 153 pages

Summary


The Global Biosimilars Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Biosimilars industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Biosimilars market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The Biosimilars industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 172 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Biosimilars Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Biosimilars
1.1.1 Definition of Biosimilars
1.1.2 Specifications of Biosimilars
1.2 Classification of Biosimilars
1.2.1 Recombinant non-glycosylated proteins
1.2.2 Recombinant glycosylated proteins
1.2.3 Recombinant peptides
1.3 Applications of Biosimilars
1.4 Industry Chain Structure of Biosimilars
1.5 Industry Overview and Major Regions Status of Biosimilars
1.5.1 Industry Overview of Biosimilars
1.5.2 Global Major Regions Status of Biosimilars
1.6 Industry Policy Analysis of Biosimilars
1.7 Industry News Analysis of Biosimilars

2 Manufacturing Cost Structure Analysis of Biosimilars
2.1 Raw Material Suppliers and Price Analysis of Biosimilars
2.2 Equipment Suppliers and Price Analysis of Biosimilars
2.3 Labor Cost Analysis of Biosimilars
2.4 Other Costs Analysis of Biosimilars
2.5 Manufacturing Cost Structure Analysis of Biosimilars
2.6 Manufacturing Process Analysis of Biosimilars
2.7 Global Price, Cost and Gross of Biosimilars 2010-2015

3 Technical Data and Manufacturing Plants Analysis of Biosimilars
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Global Key Biosimilars Manufacturers in 2014
3.3 RandD Status and Technology Source of Global Biosimilars Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of Global Biosimilars Key Manufacturers in 2014

4 Production Analysis of Biosimilars by Regions, Type, and Applications
4.1 Global Production of Biosimilars by Regions 2010-2015
4.2 Global Production of Biosimilars by Type 2010-2015
4.3 Global Production of Biosimilars by Applications 2010-2015
4.4 Price Analysis of Global Biosimilars Key Manufacturers in 2015
4.5 US Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilars 2010-2015
4.6 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilars 2010-2015
4.7 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilars 2010-2015
4.8 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilars 2010-2015

5 Consumption Volume and Consumption Value Analysis of Biosimilars by Regions
5.1 Global Consumption Volume of Biosimilars by Regions 2010-2015
5.2 Global Consumption Value of Biosimilars by Regions 2010-2015
5.3 Global Consumption Price Analysis of Biosimilars by Regions 2010-2015

6 Analysis of Biosimilars Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity and Production of Biosimilars 2010-2015
6.2 Production Market Share Analysis of Biosimilars 2010-2015
6.3 Sales Overview of Biosimilars 2010-2015
6.4 Supply, Sales and Gap of Biosimilars 2010-2015
6.5 Import, Export and Consumption of Biosimilars 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Biosimilars 2010-2015

7 Analysis of Biosimilars Industry Key Manufacturers
7.1 Hospira
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Contact Information

7.2 Sandoz International(Division Of Novartis International )
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Contact Information

7.3 Teva
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Contact Information

7.4 Roche
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Contact Information

7.5 Amgen
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Contact Information

7.6 Biocon
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 Contact Information

7.7 Dr. Reddy's Laboratories
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Contact Information

7.8 Celltrion
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Contact Information

7.9 Mylan
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Contact Information

7.10 Actavis
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Contact Information

7.11 Merck
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Contact Information

8 Price and Gross Margin Analysis of Biosimilars
8.1 Analysis of Price, Supply and Consumption
8.1.1 Price Analysis
8.1.2 Supply Analysis
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Biosimilars Product Types
8.5 Market Share Analysis of Different Biosimilars Price Levels
8.6 Gross Margin Analysis of Different Biosimilars Applications

9 Marketing Trader or Distributor Analysis of Biosimilars
9.1 Marketing Channels Status of Biosimilars
9.2 Traders or Distributors of Biosimilars with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Biosimilars
9.4 Regional Import, Export and Trade Analysis of Biosimilars

10 Development Trend of Biosimilars Industry 2016-2021
10.1 Capacity and Production Overview of Biosimilars 2016-2021
10.2 Production Market Share Analysis of Biosimilars 2016-2021
10.3 Sales Overview of Biosimilars 2016-2021
10.4 Supply, Sales, and Gap of Biosimilars 2016-2021
10.5 Import, Export and Consumption of Biosimilars 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Biosimilars 2016-2021

11 Industry Chain Suppliers with Contact Information of Biosimilars
11.1 Major Raw Materials Suppliers with Contact Information of Biosimilars Industry
11.2 Manufacturing Equipment Suppliers of Biosimilars with Contact Information
11.3 Major Suppliers of Biosimilars with Contact Information
11.4 Key Consumers of Biosimilars with Contact Information
11.5 Supply Chain Relationship Analysis of Biosimilars

12 New Project Investment Feasibility Analysis of Biosimilars
12.1 New Project SWOT Analysis of Biosimilars
12.2 New Project Investment Feasibility Analysis of Biosimilars

13 Conclusion of the Global Biosimilars Industry 2015 Market Research Report




List of Tables and Figures
Figure Picture of Biosimilars
Table Specifications of Biosimilars
Table Classification of Biosimilars
Figure Global Production Market Share of Biosimilars by Type in 2015
Figure Recombinant non-glycosylated proteins Picture
Figure Recombinant glycosylated proteins Picture
Figure Recombinant peptides Picture
Table Application Fields of Biosimilars Products
Figure 2015 Global Biosimilars Major Applications Sales Share
Figure Industry Chain Structure of Biosimilars
Table Global Major Regions Biosimilars Development Status
Table Industry Policy of Biosimilars
Table Industry News List of Biosimilars
Table Biosimilars Major Raw Materials List
Table Manufacturing Cost Structure Analysis of Biosimilars in 2014
Figure Manufacturing Process Analysis of Biosimilars
Figure Global Price Analysis of Biosimilars 2010-2015 (USD/Dose)
Figure Global Cost Analysis of Biosimilars 2010-2015 (USD/Dose)
Figure Global Gross Analysis of Biosimilars 2010-2015
Table Capacity (Doses) and Commercial Production Date of Global Biosimilars Key Manufacturers in 2014
Table Manufacturing Plants Distribution of Global Key Biosimilars Manufacturers in 2014
Table RandD Status and Technology Source of Global Biosimilars Key Manufacturers in 2014
Table Raw Materials Sources Analysis of Global and China Biosimilars Key Manufacturers in 2014
Table Global Production of Biosimilars by Regions 2010-2015 (Doses)
Figure Global Production Market Share of Biosimilars by Regions in 2014
Table Global Production of Biosimilars by Type 2010-2015 (Doses)
Figure Global Production Market Share of Biosimilars by Type in 2014
Table Global Production of Biosimilars by Applications 2010-2015 (Doses)
Figure Global Production Market Share of Biosimilars by Applications in 2014
Figure Price Comparison of Global Biosimilars Key Manufacturers in 2015 (USD/Dose)
Table US Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilars 2010-2015
Table US Supply, Import, Export and Consumption of Biosimilars 2010-2015 (Doses)
Table EU Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilars 2010-2015
Table EU Supply, Import, Export and Consumption of Biosimilars 2010-2015 (Doses)
Table Japan Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilars 2010-2015
Table Japan Supply, Import, Export and Consumption of Biosimilars 2010-2015 (Doses)
Table China Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilars 2010-2015
Table China Supply, Import, Export and Consumption of Biosimilars 2010-2015 (Doses)
Table Global Consumption Volume of Biosimilars by Regions 2010-2015 (Doses)
Figure Global Consumption Volume of Biosimilars by Regions in 2010 (Doses)
Figure Global Consumption Volume of Biosimilars by Regions in 2011 (Doses)
Figure Global Consumption Volume of Biosimilars by Regions in 2012 (Doses)
Figure Global Consumption Volume of Biosimilars by Regions in 2013 (Doses)
Figure Global Consumption Volume of Biosimilars by Regions in 2014 (Doses)
Figure Global Consumption Volume of Biosimilars by Regions in 2015 (Doses)
Table Global Consumption Value of Biosimilars by Regions 2010-2015 (M USD)
Figure Global Consumption Value of Biosimilars by Regions in 2010 (M USD)
Figure Global Consumption Value of Biosimilars by Regions in 2011 (M USD)
Figure Global Consumption Value of Biosimilars by Regions in 2012 (M USD)
Figure Global Consumption Value of Biosimilars by Regions in 2013 (M USD)
Figure Global Consumption Value of Biosimilars by Regions in 2014 (M USD)
Figure Global Consumption Value of Biosimilars by Regions in 2015 (M USD)
Table Consumption Price of Biosimilars by Regions 2010-2015 (USD/Dose)
Table Global and Major Manufacturers Capacity of Biosimilars 2010-2015 (Doses)
Table Global Capacity Market Share of Major Biosimilars Manufacturers 2010-2015
Table Global and Major Manufacturers Production of Biosimilars 2010-2015 (Doses)
Table Global Production Market Share of Major Biosimilars Manufacturers 2010-2015
Figure Global Capacity (Doses), Production (Doses) and Growth Rate of Biosimilars 2010-2015
Figure Global Capacity Utilization Rate of Biosimilars 2010-2015
Table Global and Major Manufacturers Revenue of Biosimilars 2010-2015 (M USD)
Table Global Revenue Market Share of Major Biosimilars Manufacturers 2010-2015
Figure Global Revenue (M USD) and Growth Rate of Biosimilars 2010-2015
Table China and Major Manufacturers Capacity of Biosimilars 2010-2015 (Doses)
Table Capacity Market Share of China Major Biosimilars Manufacturers 2010-2015
Table China and Major Manufacturers Production of Biosimilars 2010-2015 (Doses)
Table Production Market Share of China Major Biosimilars Manufacturers 2010-2015
Figure China Capacity (Doses), Production (Doses) and Growth Rate of Biosimilars 2010-2015
Figure China Capacity Utilization Rate of Biosimilars 2010-2015
Table China and Major Manufacturers Revenue of Biosimilars 2010-2015 (M USD)
Table Revenue Market Share of China Major Manufacturers 2010-2015
Figure China Revenue (M USD) and Growth Rate of Biosimilars 2010-2015
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2010
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2011
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2012
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2013
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2014
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2015
Figure China Production Market Share of Major Biosimilars Manufacturers in 2010
Figure China Production Market Share of Major Biosimilars Manufacturers in 2011
Figure China Production Market Share of Major Biosimilars Manufacturers in 2012
Figure China Production Market Share of Major Biosimilars Manufacturers in 2013
Figure China Production Market Share of Major Biosimilars Manufacturers in 2014
Figure China Production Market Share of Major Biosimilars Manufacturers in 2015
Figure Global Sales (Doses) and Growth Rate of Biosimilars 2010-2015
Figure China Sales (Doses) and Growth Rate of Biosimilars 2010-2015
Table Global Supply, Sales and Gap of Biosimilars 2010-2015 (Doses)
Table China Supply, Sales and Gap of Biosimilars 2010-2015 (Doses)
Table China Import, Export and Consumption of Biosimilars 2010-2015 (Doses)
Table Price of Global Biosimilars Major Manufacturers 2010-2015 (USD/Dose)
Figure Price Comparison by Global Major Biosimilars Manufacturers in 2014 (USD/Dose)
Table Gross Margin of Global Biosimilars Major Manufacturers 2010-2015
Figure Gross Margin of Global Biosimilars Major Manufacturers in 2014
Table Global and Major Manufacturers Revenue of Biosimilars 2010-2015 (M USD)
Table Global Revenue Market Share of Major Biosimilars Manufacturers 2010-2015
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2011
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2012
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2013
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2014
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2015
Table China and Major Manufacturers Revenue of Biosimilars 2010-2015 (M USD)
Table Revenue Market Share of China Biosimilars Major Manufacturers 2010-2015
Table Global Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilars 2010-2015
Table China Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilars 2010-2015
Figure Biosimilars Picture and Specifications of Hospira
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Hospira 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Hospira 2010-2015
Figure Biosimilars Production (Doses) and Global Market Share of Hospira 2010-2015
Figure Biosimilars Picture and Specifications of Sandoz International(Division Of Novartis International )
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sandoz International(Division Of Novartis International ) 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Sandoz International(Division Of Novartis International ) 2010-2015
Figure Biosimilars Production (Doses) and Global Market Share of Sandoz International(Division Of Novartis International ) 2010-2015
Figure Biosimilars Picture and Specifications of Teva
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Teva 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Teva 2010-2015
Figure Biosimilars Production (Doses) and Global Market Share of Teva 2010-2015
Figure Biosimilars Picture and Specifications of Roche
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Roche 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Roche 2010-2015
Figure Biosimilars Production (Doses) and Global Market Share of Roche 2010-2015
Figure Biosimilars Picture and Specifications of Amgen
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Amgen 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Amgen 2010-2015
Figure Biosimilars Production (Doses) and Global Market Share of Amgen 2010-2015
Figure Biosimilars Picture and Specifications of Biocon
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biocon 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Biocon 2010-2015
Figure Biosimilars Production (Doses) and Global Market Share of Biocon 2010-2015
Figure Biosimilars Picture and Specifications of Dr. Reddy's Laboratories
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dr. Reddy's Laboratories 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Dr. Reddy's Laboratories 2010-2015
Figure Biosimilars Production (Doses) and Global Market Share of Dr. Reddy's Laboratories 2010-2015
Figure Biosimilars Picture and Specifications of Celltrion
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Celltrion 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Celltrion 2010-2015
Figure Biosimilars Production (Doses) and Global Market Share of Celltrion 2010-2015
Figure Biosimilars Picture and Specifications of Mylan
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Mylan 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Mylan 2010-2015
Figure Biosimilars Production (Doses) and Global Market Share of Mylan 2010-2015
Figure Biosimilars Picture and Specifications of Actavis
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Actavis 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Actavis 2010-2015
Figure Biosimilars Production (Doses) and Global Market Share of Actavis 2010-2015
Figure Biosimilars Picture and Specifications of Merck
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Merck 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Merck 2010-2015
Figure Biosimilars Production (Doses) and Global Market Share of Merck 2010-2015
Table Gross Margin of Biosimilars by Regions 2010-2015
Table Price Comparison of Biosimilars by Regions 2010-2015 (USD/Dose)
Table Price of Different Biosimilars Product Types (USD/Dose)
Table Market Share of Different Biosimilars Price Level
Table Gross Margin of Different Biosimilars Applications
Table Traders or Distributors of Biosimilars with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Biosimilars (USD/Dose)
Table Regional Import, Export, and Trade of Biosimilars (Doses)
Figure Global Capacity (Doses), Production (Doses) and Growth Rate of Biosimilars 2016-2021
Figure Global Capacity Utilization Rate of Biosimilars 2016-2021
Figure China Capacity (Doses), Production (Doses) and Growth Rate of Biosimilars 2016-2021
Figure China Capacity Utilization Rate of Biosimilars 2016-2021
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2016
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2021
Figure Production Market Share of China Major Biosimilars Manufacturers in 2016
Figure Production Market Share of China Major Biosimilars Manufacturers in 2021
Figure Global and China Sales (Doses) and Growth Rate of Biosimilars 2016-2021
Table Global Supply, Sales and Gap of Biosimilars 2016-2021 (Doses)
Table China Supply, Sales and Gap of Biosimilars 2016-2021 (Doses)
Table China Production, Import, Export and Consumption of Biosimilars 2016-2021 (Doses)
Table Global Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilars 2016-2021
Table China Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilars 2016-2021
Table Major Raw Materials Suppliers with Contact Information of Biosimilars
Table Manufacturing Equipment Suppliers of Biosimilars with Contact Information
Table Major Suppliers of Biosimilars with Contact Information
Table Key Consumers of Biosimilars with Contact Information
Figure Supply Chain Relationship Analysis of Biosimilars
Table New Project SWOT Analysis of Biosimilars
Table New Project Investment Feasibility Analysis of Biosimilars
Table Part of Interviewees Record List

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, ...

Biosimilar - Global Market Outlook (2016-2022)

Biosimilar - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...


Download Unlimited Documents from Trusted Public Sources

Biosimilar Industry in Europe

  • November 2016
    42 pages
  • Biosimilar  

  • Europe  

View report >

Pathology Statistics in Canada

  • October 2016
    2 pages
  • Biosimilar  

  • Canada  

    North America  

View report >

Global Breast Cancer Statistics

  • October 2016
    2 pages
  • Breast Cancer  

    Biosimilar  

  • Europe  

    World  

    Hungary  

View report >

Bioprocessing Industry

3 months ago

Biosimilar Statistics

3 months ago

Biosimilar Statistics

3 months ago

Related Market Segments :

Biosimilar

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.